@HalfBloodPrince Ji
QIB number is just one factor among many and none of factor is 100% full proof. One need to make decisions considering various factors together.
Maybe serious Institution buyers didn't come up and as per my observation they usually don't come up in preopen which set listing price and they are also allowed to sell on listing so some may thought of booking profit on listing. Maybe on listing price they didn't find it attractive on valuation front so they didn't buy it further. There can be various reasons.
But this company is definitely good with decent business especially focus towards CV business which has good future prospects.
If I would had got allotment then I would have held it as portfolio stock though I have Sansera so I didn't buy it fresh.
@Master Eagle Ji
Was busy in something and I missed all of you as well:)
@Crow Ji
We all have different risk appetite and time horizon for investment so I understand and respect your approach as well.Post 2021 now it's rare to make 50-100% kind of return on listing in big size IPOs with decent allotment chance.
I believe in applying only those businesses which I can hold as portfolio stock irrespective of listing as per my research and understanding and reap multifold return and they worked as well in many like MTAR, Mrs Bector, Medanta, Syrma, Cyient etc
@IpoZINDAHAI Ji,
You got my point:)
@Ascension Ji,
I can't generalise for everyone and people are free to make their own decisions and I respect everyone perspective and many are very senior and learned members than me. I can only share my way of seeing things and my way of execution.
Thanks 🙏